Solara Active Pharma Sciences Limited (SOLARA.NS)
INR 725.65
(1.82%)
INR 725.65
(1.82%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -3.85 Billion INR | -800.04% |
| 2022 | 275.9 Million INR | 206.16% |
| 2021 | -259.89 Million INR | -109.13% |
| 2020 | 2.84 Billion INR | 64.34% |
| 2019 | 1.73 Billion INR | 14.74% |
| 2018 | 1.5 Billion INR | 420.76% |
| 2017 | 289.84 Million INR | -50.41% |
| 2016 | 584.42 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 168.5 Million INR | 222.19% |
| 2024 Q2 | 359.7 Million INR | 113.47% |
| 2023 Q4 | -137.9 Million INR | 92.65% |
| 2023 FY | -1.93 Billion INR | -800.04% |
| 2023 Q1 | -67.9 Million INR | -125.15% |
| 2023 Q2 | 126 Million INR | 285.57% |
| 2023 Q3 | -1.87 Billion INR | -1589.29% |
| 2022 Q2 | 26.6 Million INR | 117.07% |
| 2022 Q4 | 270 Million INR | 11.62% |
| 2022 FY | 275.9 Million INR | 206.16% |
| 2022 Q1 | -155.8 Million INR | -9.03% |
| 2022 Q3 | 241.9 Million INR | 809.4% |
| 2021 Q2 | 434.8 Million INR | -31.79% |
| 2021 FY | -259.89 Million INR | -109.13% |
| 2021 Q1 | 637.4 Million INR | -14.88% |
| 2021 Q4 | -142.9 Million INR | 88.59% |
| 2021 Q3 | -1.25 Billion INR | -388.13% |
| 2020 Q1 | 575.7 Million INR | 87.28% |
| 2020 Q4 | 748.8 Million INR | -3.94% |
| 2020 FY | 2.84 Billion INR | 64.34% |
| 2020 Q2 | 700.2 Million INR | 21.63% |
| 2020 Q3 | 779.5 Million INR | 11.33% |
| 2019 Q4 | 307.4 Million INR | -42.88% |
| 2019 Q3 | 538.2 Million INR | 20.89% |
| 2019 Q2 | 445.2 Million INR | 9.14% |
| 2019 FY | 1.73 Billion INR | 14.74% |
| 2019 Q1 | 407.9 Million INR | -25.1% |
| 2018 FY | 1.5 Billion INR | 420.76% |
| 2018 Q4 | 544.58 Million INR | 33.61% |
| 2018 Q3 | 407.6 Million INR | 41.87% |
| 2018 Q2 | 287.3 Million INR | 6.45% |
| 2018 Q1 | 269.9 Million INR | 6.26% |
| 2017 Q2 | 83.33 Million INR | -58.97% |
| 2017 Q1 | 203.09 Million INR | 0.0% |
| 2017 FY | 289.84 Million INR | -50.41% |
| 2017 Q4 | 254 Million INR | 0.0% |
| 2016 FY | 584.42 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Sigachi Industries Limited | 1.47 Billion INR | 361.409% |
| Ind-Swift Limited | 1.22 Billion INR | 414.275% |
| Bajaj HealthCare Limited | - INR | Infinity% |
| Sakar Healthcare Limited | 495.5 Million INR | 877.569% |
| Aurobindo Pharma Limited | 104.5 Billion INR | 103.687% |
| Innova Captab Limited | 2.53 Billion INR | 252.084% |
| Divi's Laboratories Limited | 18.31 Billion INR | 121.043% |
| AstraZeneca Pharma India Limited | 4.47 Billion INR | 186.119% |
| Morepen Laboratories Limited | 4.17 Billion INR | 192.311% |
| Mankind Pharma Limited | 40.86 Billion INR | 109.428% |
| Sequent Scientific Limited | - INR | Infinity% |
| Wanbury Limited | 1.7 Billion INR | 325.684% |
| Laurus Labs Limited | 3.94 Billion INR | 197.576% |
| Nectar Lifesciences Limited | 3.89 Billion INR | 199.031% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | 142.909% |
| Alembic Limited | 767.77 Million INR | 601.83% |
| Hikal Limited | 1.49 Billion INR | 357.857% |
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | 166.913% |
| Neuland Laboratories Limited | 5.31 Billion INR | 172.449% |
| J. B. Chemicals & Pharmaceuticals Limited | 7.54 Billion INR | 151.088% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | 159.254% |
| IOL Chemicals and Pharmaceuticals Limited | 4.94 Billion INR | 177.959% |
| Themis Medicare Limited | 1.3 Billion INR | 395.671% |
| RPG Life Sciences Limited | 2.29 Billion INR | 268.08% |
| Zydus Lifesciences Limited | 45.39 Billion INR | 108.488% |
| Lupin Limited | 27.75 Billion INR | 113.88% |
| Amrutanjan Health Care Limited | 621.02 Million INR | 720.408% |
| Wockhardt Limited | 140 Million INR | 2852.071% |
| Vaishali Pharma Limited | 6.29 Million INR | 61315.443% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | 223.17% |
| Jagsonpal Pharmaceuticals Limited | 214.04 Million INR | 1900.084% |
| Jubilant Pharmova Limited | 5.18 Billion INR | 174.251% |
| FDC Limited | 3.03 Billion INR | 227.002% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 105.689% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | 1951.911% |
| Eris Lifesciences Limited | 5.18 Billion INR | 174.356% |
| Venus Remedies Limited | 534.65 Million INR | 820.638% |
| ZIM Laboratories Limited | 1.09 Billion INR | 450.866% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | 412.989% |
| Par Drugs and Chemicals Limited | 551.58 Million INR | 798.509% |
| Caplin Point Laboratories Limited | 7.22 Billion INR | 153.325% |
| Shilpa Medicare Limited | 3.76 Billion INR | 202.428% |
| Albert David Limited | 1.33 Billion INR | 388.724% |
| Ajanta Pharma Limited | 19.67 Billion INR | 119.58% |
| Hester Biosciences Limited | 364.77 Million INR | 1156.255% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | 183.62% |
| Gufic Biosciences Limited | 2.89 Billion INR | 233.143% |
| Windlas Biotech Limited | 1.29 Billion INR | 396.63% |
| Procter & Gamble Health Limited | 2.78 Billion INR | 238.295% |
| Aarey Drugs & Pharmaceuticals Limited | 2.83 Million INR | 136205.151% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | 14131.976% |
| Granules India Limited | 6.52 Billion INR | 159.019% |
| Aarti Drugs Limited | 7.14 Billion INR | 153.896% |
| Bal Pharma Limited | 214.56 Million INR | 1895.646% |
| Alkem Laboratories Limited | 19.46 Billion INR | 119.797% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 103.694% |
| Lincoln Pharmaceuticals Limited | 1.9 Billion INR | 302.111% |
| Medicamen Biotech Limited | - INR | Infinity% |
| Unichem Laboratories Limited | - INR | Infinity% |
| Bafna Pharmaceuticals Limited | 237.66 Million INR | 1721.175% |
| Biofil Chemicals and Pharmaceuticals Limited | 20.65 Million INR | 18752.692% |
| Valiant Laboratories Limited | - INR | Infinity% |
| Orchid Pharma Limited | 2.36 Billion INR | 263.184% |
| Medico Remedies Limited | 277.11 Million INR | 1490.346% |
| Ind-Swift Laboratories Limited | 2 Billion INR | 291.779% |
| Ipca Laboratories Limited | 29.59 Billion INR | 113.018% |
| Brooks Laboratories Limited | -72.25 Million INR | -5232.586% |
| Syncom Formulations (India) Limited | 249.25 Million INR | 1645.791% |
| Piramal Enterprises Limited | - INR | Infinity% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | 115.208% |
| NATCO Pharma Limited | 25.96 Billion INR | 114.841% |
| Suven Life Sciences Limited | -1.22 Billion INR | -214.312% |
| Krebs Biochemicals & Industries Limited | - INR | Infinity% |
| Strides Pharma Science Limited | 5.22 Billion INR | 173.728% |
| Indoco Remedies Limited | 1.52 Billion INR | 352.749% |
| Alpa Laboratories Limited | 61.51 Million INR | 6363.35% |
| Lasa Supergenerics Limited | -458 Million INR | -741.235% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 6.37% |